News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Chembio Diagnostics, Inc. To Hold Conference Call Today At 4:30 ET To Discuss Marketing Partner Agreements For Rapid HIV Tests
October 10, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK--(BUSINESS WIRE)--Chembio Diagnostics, Inc. (OTCBB:CEMI) will host a conference call today, Tuesday October 10th at 4:30pm ET to discuss the recently announced financing and marketing partner agreements for Chembio’s rapid HIV tests.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Diabetes
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
July 20, 2026
·
7 min read
·
Michael Gibney
Alzheimer’s disease
AAIC 2026: Anti-tau space begins to clarify as Biogen presents detailed data on antisense drug
July 15, 2026
·
6 min read
·
Heather McKenzie
Alzheimer’s disease
AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist
July 10, 2026
·
6 min read
·
Michael Gibney
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
·
2 min read
·
Jef Akst